Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia.
10.3760/cma.j.issn.0253-2727.2023.02.019
- Author:
Fang Yuan ZHENG
1
;
Miao WANG
1
;
Lei Ping ZHANG
1
;
Qian JIANG
2
Author Information
1. Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China.
2. Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Child;
Tyrosine Protein Kinase Inhibitors;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;
Protein Kinase Inhibitors/therapeutic use*;
Chronic Disease
- From:
Chinese Journal of Hematology
2023;44(2):174-176
- CountryChina
- Language:Chinese
